CAD 0.43
(6.25%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -18.17 Million CAD | 35.33% |
2022 | -28.11 Million USD | -557.03% |
2021 | -4.27 Million CAD | 55.54% |
2020 | -9.62 Million CAD | -174.02% |
2019 | 13 Million CAD | 1099.12% |
2018 | -1.3 Million CAD | -1003.77% |
2017 | -117.9 Thousand CAD | -121.51% |
2016 | -53.22 Thousand CAD | -206.98% |
2015 | -17.33 Thousand CAD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -10.44 Million USD | 24.24% |
2024 Q2 | -6.32 Million USD | 39.49% |
2023 Q4 | -13.78 Million USD | 22.84% |
2023 Q1 | -23.35 Million USD | 16.94% |
2023 Q3 | -17.86 Million USD | 13.22% |
2023 FY | -18.17 Million CAD | 35.33% |
2023 Q2 | -20.59 Million USD | 11.82% |
2022 Q2 | -44.62 Million CAD | 9.47% |
2022 FY | -28.11 Million USD | -557.03% |
2022 Q1 | -49.29 Million CAD | -1051.99% |
2022 Q3 | -42.91 Million CAD | 3.83% |
2022 Q4 | -28.11 Million USD | 34.49% |
2021 Q1 | -15.97 Million CAD | -65.98% |
2021 FY | -4.27 Million CAD | 55.54% |
2021 Q4 | -4.27 Million CAD | 41.38% |
2021 Q3 | -7.29 Million CAD | 44.82% |
2021 Q2 | -13.22 Million CAD | 17.2% |
2020 Q2 | -10.53 Million CAD | -179.72% |
2020 FY | -9.62 Million CAD | -174.02% |
2020 Q4 | -9.62 Million CAD | -11.71% |
2020 Q3 | -8.61 Million CAD | 18.23% |
2020 Q1 | 13.21 Million CAD | 1.65% |
2019 FY | 13 Million CAD | 1099.12% |
2019 Q4 | 13 Million CAD | 0.0% |
2018 FY | -1.3 Million CAD | -1003.77% |
2017 FY | -117.9 Thousand CAD | -121.51% |
2016 FY | -53.22 Thousand CAD | -206.98% |
2015 FY | -17.33 Thousand CAD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Therma Bright Inc. | -91.84 Thousand CAD | -19693.69% |
Theralase Technologies Inc. | 342.96 Thousand CAD | 5400.744% |
VentriPoint Diagnostics Ltd. | -1.01 Million CAD | -1682.4% |